Ambrisentan (BSF 208075) is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy but has yet to be implicated in cases of clinically apparent acute liver injury.
Molecular Weight:
378.42
Purity:
99.65%
CAS Number:
[177036-94-1]
Formula:
C22H22N2O4
Target:
Endothelin Receptor
T1655
* VAT and and shipping costs not included. Errors and price changes excepted